Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors.
In this manuscript we apply stochastic modeling to investigate the risk of reactivation of latent mycobacterial infections in patients undergoing treatment with tumor necrosis factor inhibitors. First, we review the perspective proposed by one of the authors in a previous work and which consists in...
Main Authors: | Elena Agliari, Lorenzo Asti, Adriano Barra, Rossana Scrivo, Guido Valesini, Robert S Wallis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3557254?pdf=render |
Similar Items
-
Non-Tuberculous Mycobacterial Diseases in Children
by: Aniello Meoli, et al.
Published: (2020-07-01) -
L-Tyrosine Limits Mycobacterial Survival in Tuberculous Granuloma
by: Yaxian Gao, et al.
Published: (2023-04-01) -
The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
by: Meyad Alkarni, et al.
Published: (2023-02-01) -
Management of lymphadenitis due to non-tuberculous mycobacterial infection in children
by: Scott, C, et al.
Published: (2012) -
Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
by: Ruth, MM, et al.
Published: (2019)